Entrada Therapeutics (TRDA)
(Delayed Data from NSDQ)
$14.75 USD
-1.21 (-7.58%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $14.77 +0.02 (0.14%) 7:58 PM ET
1-Strong Buy of 5 1
B Value A Growth B Momentum A VGM
Earnings News For TRDA
-
Entrada Therapeutics Reports First Quarter 2024 Financial Results
-
Entrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
-
Entrada Therapeutics, Inc. (TRDA) Surpasses Q3 Earnings and Revenue Estimates
-
Entrada Therapeutics Reports Third Quarter 2023 Financial Results
-
Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Misses Revenue Estimates
-
Entrada Therapeutics Reports Second Quarter 2023 Financial Results
-
Entrada Therapeutics Reports First Quarter 2023 Financial Results
-
Entrada Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
-
Entrada Therapeutics Reports Third Quarter 2022 Financial Results